Review
doi: 10.1158/1078-0432.CCR-04-0886.
Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies
Affiliations
- PMID: 15623586
- DOI: 10.1158/1078-0432.CCR-04-0886
Item in Clipboard
Review
Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies
Clin Cancer Res.
.
Abstract
Human malignant tumors are characterized by abnormal proliferation resulting from alterations in cell cycle-regulatory mechanisms. The regulatory pathways controlling cell cycle phases include several oncogenes and tumor suppressor genes that display a range of abnormalities with potential usefulness as markers of evolution or treatment response in ovarian cancer. This review summarizes the current knowledge about these aberrations in malignant tumors of the ovary. We sought to divide cell cycle-regulatory genes into four subgroups on the basis of their predominant role in a specific phase or during the transition between two phases of the cell cycle.
Similar articles
-
Role of cell-cycle regulatory proteins in gynecological cancer.J Cell Physiol. 2003 Aug;196(2):224-44. doi: 10.1002/jcp.10286. J Cell Physiol. 2003. PMID: 12811815 Review.
-
The role of cell cycle regulatory proteins in the pathogenesis of melanoma.Pathology. 2006 Aug;38(4):287-301. doi: 10.1080/00313020600817951. Pathology. 2006. PMID: 16916716
-
Cell cycle deregulation: a common motif in cancer.Prog Cell Cycle Res. 2003;5:5-18. Prog Cell Cycle Res. 2003. PMID: 14593696 Review.
-
Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.Hum Pathol. 2006 Jun;37(6):648-55. doi: 10.1016/j.humpath.2006.01.023. Hum Pathol. 2006. PMID: 16733203
-
14-3-3 proteins as potential oncogenes.Semin Cancer Biol. 2006 Jun;16(3):203-13. doi: 10.1016/j.semcancer.2006.03.004. Epub 2006 Apr 1. Semin Cancer Biol. 2006. PMID: 16725345 Review.
Cited by
-
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.Int J Cancer. 2013 May 15;132(10):2258-69. doi: 10.1002/ijc.27917. Epub 2012 Nov 21. Int J Cancer. 2013. PMID: 23114871 Free PMC article.
-
p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.Mol Cancer. 2010 Jul 3;9:175. doi: 10.1186/1476-4598-9-175. Mol Cancer. 2010. PMID: 20598155 Free PMC article.
-
The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.Int J Mol Sci. 2024 Apr 5;25(7):4060. doi: 10.3390/ijms25074060. Int J Mol Sci. 2024. PMID: 38612869 Free PMC article.
-
Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.Biomark Res. 2023 Apr 24;11(1):44. doi: 10.1186/s40364-023-00480-x. Biomark Res. 2023. PMID: 37095586 Free PMC article.
-
Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.J Exp Clin Cancer Res. 2016 Aug 27;35(1):127. doi: 10.1186/s13046-016-0403-2. J Exp Clin Cancer Res. 2016. PMID: 27567667 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
